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A changing paradigm for health research
 Research often fails to inform the choices faced by clinicians,
patients, payors, policy-makers
 Need head-to-head comparisons of all relevant choice options and
combinations
 Need evidence on effectiveness in real-world clinical & community
settings
 Need to know whether/why interventions work for some and not for
others (treatment heterogeneity)
 Need to determine value from the consumer’s perspective
(patient-centered outcomes and costs)

CER Defined
 “Comparative effectiveness research is the generation and synthesis
of evidence that compares the benefits and harms of alternative
methods to prevent, diagnose, treat, and monitor disease and
improve the delivery of care.
 The purpose of CER is to assist consumers, clinicians, purchasers, and
policy makers to make informed decisions that will improve health
care at both the individual and population levels.”
-National Academy of Sciences
Institute of Medicine, 2009

PCOR Defined
Patient-Centered Outcomes Research (PCOR) helps people and their caregivers
communicate and make informed health care decisions, allowing their voices to
be heard in assessing the value of health care options. This research answers
patient-centered questions such as:
• “Given my personal characteristics, conditions and preferences, what should
I expect will happen to me?”
• “What are my options and what are the potential benefits and harms of
those options?”
• “What can I do to improve the outcomes that are most important to me?”
• “How can clinicians and the care delivery systems they work in help me
make the best decisions about my health and healthcare?”

PCOR Defined
To answer these questions, PCOR:
• Assesses the benefits and harms of preventive, diagnostic, therapeutic,
palliative, or health delivery system interventions to inform decision making,
highlighting comparisons and outcomes that matter to people;
• Is inclusive of an individual’s preferences, autonomy and needs, focusing on
outcomes that people notice and care about such as survival, function,
symptoms, and health related quality of life;
• Incorporates a wide variety of settings and diversity of participants to address
individual differences and barriers to implementation and dissemination; and
• Investigates optimizing outcomes while addressing burden to individuals,
availability of services, technology, and personnel, and other stakeholder
perspectives

Recent developmental history

 2003 Medicare Modernization Act: $30M annually for research to improve
quality, effectiveness, efficiency
 2007 federal legislation to expand CER passed House
but failed Senate
 2009 ARRA: $1.1B to NIH and AHRQ for CER
Federal Coordinating Council for CER established
IOM Top 100 Priority Topics for CER identified
 50% involve health care delivery system
 33% address health care disparities
 20% address patient functional limitations or disabilities
 2010 ACA: scale up to ≈$500M annually through Patient Centered Outcomes
Research Institute
 2011 ACA: $10M for Public Health CER at CDC

PCOR Research Priorities






Assessment of prevention, diagnosis, and treatment options
Improving healthcare systems
Communication and dissemination research
Addressing health disparities
Accelerating Patient-Centered Outcomes Research and
Methodological Research

Prevention & Treatment Options Research

• Compare the effectiveness of two or more strategies for prevention, treatment,
screening, diagnosis, or management that have not been adequately studied against
alternative options. Topics are not limited to medical or surgical therapy and may include
a range of strategies including self-care.
• Special emphasis is placed on studies conducted in typical clinical populations
considering the full range of relevant patient-centered outcomes and possibilities that
results may differ among patient groups based on patient characteristics (understood
broadly as possibly including clinical, psychosocial, demographic, and other domains) or
preferences.
• Compare the use of prognostication/risk-stratification tools with usual clinical
approaches to treatment selection or administration.
• Compare the key determinants of the outcomes patients experience following treatment
decisions, with attention to various patient factors, including demographic, biological,
clinical, social, economic, and geographic factors that may influence the outcomes that
follow a specific treatment.

Delivery Systems Research
• Research that compares alternative system-level approaches to supporting and
improving patient access to care; receipt of appropriate evidence-based care; the
quality, timeliness, and safety of the patient care experience; decision-making based
on patients’ personal values; and self-care.
• Research that compares alternative approaches to models of care delivery or
coordination of care across healthcare services or settings, including care for patients
with complex, chronic, and/or multiple conditions, are of interest. The emphasis is on
comparing approaches for their effect on patients and, when relevant, their caregivers,
in ways that they experience and think are important.
• Research that compares alternative system-level approaches that aim to improve the
efficiency of health care delivery to patient populations. These may include efforts to
reduce the use of ineffective or wasteful care, to reduce redundant and duplicative
care, to shorten waiting times, or enhance the timeliness and quality of
communications during referrals and transitions in care.

Communication & Dissemination Research
• Compare alternative communication, dissemination, health literacy and/or
implementation strategies that aim to improve patients’ health outcomes, by increasing
patient, caregiver, and/or provider awareness of health care options in clinical or
community-based settings.
• Compare the effectiveness of alternative approaches across a range of patient centered
outcomes to increase or encourage effective patient, caregiver, or clinician
participation in care decisions and in shared decision making.
• Compare alternative methods and tools to elicit and include patient desired outcomes
in the health care decision making process.
• Compare alternative approaches, including use of public health strategies or social
media, for providing new information to patients, caregivers, or clinicians, with
attention to differences in effectiveness in different populations.
• Compare innovative approaches in the use of existing electronic clinical data and other
electronic modalities from the healthcare system or from a network of systems to
enhance clinical decision making by patients and providers.

Disparities Research

• Compare interventions to reduce or eliminate disparities in patient-centered
outcomes, including health, health care, and patient-reported outcomes. For
example, by accounting for possible differences at the patient, provider, or systems
level, determine what interventions can be most effective for eliminating disparities
in outcomes.
• Compare promising practices that address contextual factors such as socioeconomic,
demographic, or community factors and their impact on patient-centered health
outcomes.
• Compare benefits and risks of treatment, diagnostic, prevention, or service options
across different patient populations, with attention to eliminating disparities.
• Research that compares strategies to overcome patient, provider, or systems level
barriers (e.g. language, culture, transportation, homelessness, unemployment, lack
of family/caregiver support) that may adversely affect patients and are relevant to
their choices for preventive, diagnostic, and treatment strategies—as well as patientcentered outcomes.
• Compare and identifies best practices within various patient populations for
information sharing about treatment outcomes and research.

Methods Research
• Identify optimal methods for engaging patients in the research process, and methods
for evaluating the impact on research outcomes of patient engagement in the research
process.
• Identify methods for conduct of systematic reviews of patient-centered comparative
effectiveness research topics.
• Test methods for including patients and stakeholders in generating, selecting, and
prioritizing topics for research,
• Test methods for including patients and stakeholders in the peer‐review process.
• Improve the validity and/or efficiency of analytic methods for comparative
effectiveness research (e.g., approaches for strengthening causal inference in
observational and randomized studies; approaches to identifying and confirming
heterogeneity in treatment effects).
• Determine the validity and efficiency of data sources commonly used in PCOR.
• Develop new patient-reported outcomes measures.
• Evaluate and compare strategies for training researchers, patients, and other
stakeholders in PCOR methods.

Where Does Public Health Fit in CER/PCOR?
 Public health roles in community engagement, priority setting,
preference assessment
 Public health roles in prevention delivery
 Use of public health strategies to improve health care systems
 Public health system roles in communication and
dissemination
 Public health system roles in health information exchange,
quality measurement, and reporting
 Public health system roles in disparities reduction

Valuing Prevention & Public Health

Institute of Medicine. An Integrated Framework for Assessing the
Value of Community-Based Prevention. Washington, DC; 2012.

Methods in CER and PCOR
PCORI Draft Methodology Report
 Stakeholder engagement and patient centeredness
 Prioritizing research topics
 Choosing a study design
 Designing, conducting, and reporting results

Methods in CER and PCOR
 Prospective, pragmatic trials and “large simple trials”
 Advanced analytic methods used to strengthen internal validity and limit bias
due to selection, confounding in observational studies
 Propensity score and instrumental variables models
 Explicit testing for treatment heterogeneity
 Latent variable models for multiple interventions,
multiple outcomes
 Non-inferiority analyses
 Development and integration of large clinical and
administrative data sources and registries
 Use of Bayesian models for synthesizing data from
multiple studies, e.g. indirect treatment comparisons

Expanding Role of Pragmatic Trials

http://www.cabinetoffice.gov.uk/resource-library/test-learn-adapt-developingpublic-policy-randomised-controlled-trials

Estimating Treatment Heterogeneity
Programs/Policies/Interventions may affect some people
differently than others
Interventions may be moderated by community contextual
factors, socioeconomic conditions, cultural and linguistic
characteristics, individual health status and comorbidities
If you know and measure all relevant modifiers, traditional
statistical methods can be used
Often, important modifiers may be unknown, others imperfectly
measured
Instrumental-variables methods provide the most viable
solution for estimating “person-centered” effects

Estimating Treatment Heterogeneity

Basu et al. Estimating person-centered treatment effects using instrumental variables.
J Health Econ 2012.

Methods in CER and PCOR
PCORI Draft Methodology Report
 Stakeholder engagement and patient centeredness
 Prioritizing research topics
 Choosing a study design
 Designing, conducting, and reporting results

Example: Pragmatic Trials in PBRNs
Improving Cultural Competency of Public Health Workers
Question of interest: Can a health professions cultural
competency training program be adapted to improve skills
among local public health workers?
Practice settings: 56 local agencies
Factors examined:
– Knowledge and skills related to
CLAS standards
– RE-AIM measures of success

Study design: random-assignment delayed intervention trial

Example: Estimating Treatment Heterogeneity
in PBRNs
Effects of Medicaid Maternity Case Management Payment
Model Change in North Carolina
Policy change may affect some populations differently
from others

Women served by LHDs vs. other community providers
Women in communities with more vs.
less abundant community resources
Women with comorbid conditions and
higher-risk pregnancies
Use Bayesian CER methods, propensity score
estimation, instrumental-variables estimation for personcentered treatment (PET) effects

Example: Comparative efficiency of a
delivery system innovation
Arkansas Community Connector Program uses public
health-trained community health workers to identify and
link elderly and disabled populations to communitybased services and supports to avoid/delay need for
institutional care
Compare the CCP program to “usual practice” on
Medicaid expenditures for elderly and disabled
recipients eligible for long-term care services
Determine whether the CCP program is cost-neutral to
Medicaid after accounting for both Medicaid
expenditures and program operating costs
Felix HC, Mays GP, Stewart MK, Cottoms N, Olson M. Medicaid savings resulted when
community health workers linked those with needs to home and community care.
Health Affairs. 2011;30(7):1366-1374.

Methods: Comparison Group

CCP participants

Comparison Group: statistically
matched on age, gender, race, eligibility
category, enrollment duration, waiver
enrollment, comorbidities, prior-year
spending

Results of propensity score matching
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.8
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Distribution of Propensity Score

CCP Participants

Comparison Group

Approximate a “statistically equivalent” control group that
would be generated by random assignment. Each subject has
an equivalent probability of being a CCP participant.

Estimates of Program Impact
Regression-Adjusted Spending Estimates

CER/PCOR Funding Opportunities









PCORI: third round deadlines in Spring 2013
AHRQ: next round of awards scheduled for Spring 2013
RWJF PHSSR awards program (current deadline Dec 18)
RWJF PBRN Program (forthcoming funding 2013)
Special RWJF/CTSA solicitation this winter
NIH Common Fund: health economics program
CMS Innovation Fund projects
CDC Community Transformation Grant projects

The Robert Wood Johnson Foundation’s
Public Health PBRN Program
First cohort (December 2008 start-up)
Second cohort (January 2010 start-up)
Affiliate/Emerging PBRNs

National
Coordinating
Center

Concluding Questions
 How can we help the public health community become aware
of opportunities in PCOR and CER?
 How can we help the public health community position to be
successful with PCOR and CER funding?






Meaningful stakeholder engagement
Rigorous research design and methods
Preliminary data
Multi-network studies, large simple trials
Collaborations with primary care PBRNs, CTSAs, etc

 How can we facilitate the productive dissemination and use of
PCOR and CER evidence via the public health system?
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